Dysfunction and ceRNA network of the tumor suppressor miR-637 in cancer development and prognosis

Biomarker Research

Table 4 Prognostic values of miR-637 and miR-637 related genes

Diseases	Sample size	prognostic factor	Relationship with miR-637	Expression in high-risk patients	Clinicopathological characteristic	Prognostic value	Ref
GBM/LGG	70	miR-637	—	Low	associated with clinical stage	OS	[9]
GBM	161	miR-637	—	Low	—	OS	[11]
NSCLC	123	miR-637	—	Low	associated with TNM stage	OS	[14]
OV	281	miR-637	—	Low	—	OS	[80]
HCC	61	miR-637	—	Low	—	OS	[51]
	61	circ_0039053	Negative correlation	High	associated with TNM stage and lymph node metastasis	OS	[51]
	96	NIFKAS1	Negative correlation	High	—	OS and DFS	[18]
CRC	179	circHIPK3	Negative correlation	High	associated with recurrence, tumor size, regional lymph node metastasis, and distant metastasis	OS and DFS	[6]
TNBC	60	circSEPT9	Negative correlation	High	associated with TNM stage	OS	[29]
PCa	237	LIF	Negative correlation	High	associated with tumor metastasis	RFS	[26]

GBM glioblastoma multiforme, LGG low-grade glioma, NSCLC non-small cell lung cancer, HCC hepatocellular carcinoma, OV ovarian cancer, CRC colorectal cancer, TNBC triple-negative breast cancer, PCa prostate cancer, TNM tumor node metastasis, OS overall survival, DFS disease-free survival, RFS relapse-free survival

ISSN: 2050-7771